Barclays PLC 13D/13G Filings for Amicus Therapeutics, Inc. (FOLD)

Barclays PLC 13D and 13G filings for Amicus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-14
9:27 pm
Purchase
2026-03-3113GAMICUS THERAPEUTICS INC
FOLD
Barclays PLC17,755,672
5.650%
17,755,672increase
(New Position)
Filing